Remdesivir, the much-talked-about experimental drug used to treat COVID-19 patients, has been conditionally approved by Europe's top healthcare regulator, becoming the first drug to be "recommended for authorization" on the continent.
from FOX News https://ift.tt/2B1eIUd
Thursday, June 25, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
thank you for comment